Tags: Articles & Whitepapers, ADME/DMPK, Toxicology & Safety
Tags: Articles & Whitepapers, ADME/DMPK, Age-Related Diseases
Our popular, easy-to-follow guide: 'DDI Regulatory Guidance' is now on its 3rd edition.
Read about:
Tags: Guides, ADME/DMPK, IND Enabling Studies/Preclinical Development
The skin is the largest organ in the human body. It contains enzymes capable of drug metabolism.
In this presentation, we focus on:
View the presentation to learn more!
Tags: Presentations, ADME/DMPK
LC-MS provides the analytical endpoint for most discovery ADME assays. There is a constant drive to reduce LC-MS run times whilst maintaining quality.
In this presentation, we focus on:
View the presentation to learn more!
Tags: Presentations, ADME/DMPK
Due to an aging population, polypharmacy is increasing. Drug-drug interactions account for 5% of UK hospital admissions, and are a particular concern for common co-meds such as statins.
In this presentation, we focus on:
View the presentation to learn more!
Tags: Presentations, ADME/DMPK
Reducing the sample cycle time for LC-MS analysis is critical in increasing throughput and improving efficiency.
In this poster, we focus on:
Read our poster to learn more about our research!
In order to accurately predict human pharmacokinetics and efficacious dose, a robust measurements of clearance is essential.
In this poster, we focus on:
Read our poster to learn more about our research!
Real time mass defect filtering (MDF) on independent acquisition (IDA) scans enable the generation of simultaneous selective MS and MSMS data in one injection.
In this poster, we focus on:
Read our poster to learn more about our research!